Drugs / iNO
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05871606 | Apr 2026 → Aug 2028 expected | stroke disorder | Wake Forest University Health Sciences | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iNO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05871606 ↗ |
| Route | Inhaled | “Inhaled Nitrous Oxide” NCT05871606 ↗ |